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Abstract  
Aims: This study was to investigate the antimicrobial activity of a modified calixarene polymer bound 
to a silicone substrate in the presence of pathogens associated with catheter infections, Escherichia 
coli and Proteus mirabilis.  
Methods and Results:  The molecule and its constituent parts, were studied bound and unbound to 
silicone substrates to ascertain growth effects. Minimum inhibitory and bactericidal concentrations 
were determined against E.coli and Pr.mirabilis. Biofilm growth was studied by immersing silicone 
discs seeded with either Pr.mirabilis or E.coli in artificial urine. Biofilms were assessed at 3,7 and 10 
days. The coated material reduced bacterial cell density compared to the uncoated samples. Direct 
and indirect toxicity tests were conducted with a fibroblast cell line (3T3), coated and non-coated 
silicone samples were seeded with cells (1x104/cm2) and incubated for 72h. Hoechst Propidium 
Iodide staining identified delayed toxic effect from the coated and non-coated material leachate in 
all but the platinum cured medical grade silicone which showed no evident toxicity.  
Conclusions: The calixerene polymer was determined to be the active part of the coating. Biofilm 
formation was dramatically reduced in the coated platinum cured medical grade silicone samples 
but cell viability was reduced on the clinical grade silicones regardless of coating in contrast to cells 
seeded on the platinum cured medical grade silicone. A delayed toxic response was evident to the 
extract of the coated and non-coated clinical grade samples, indicating that the toxic effect is due to 
the underlying substrate.  
Significance and Impact of Study: This study has established that the immobilised molecule enhances 
the antibacterial and antifouling properties of silicone, without toxicity. It also clearly demonstrates 
that regardless of coating efficacy the substrate material has the capacity to disrupt its potency and 
change the nature of the material coating. 
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1 Introduction 
1.1 Catheterisation 
Catheterisation is one of the most common medical procedures in hospitals today, with uses ranging 
from the delivery of antibiotics via central venous lines to the draining of urine from the bladder. In 
2014, it was reported that 23.6% patients across 183 US hospitals had acquired a catheter-
associated urinary tract infection (CAUTI) (Magill et. al., 2014).   
 
Patients requiring urinary catheterisation are naturally predisposed to infections of both the urinary 
tract and bacteraemia, specifically relating to colonisation of the device by constituent members of 
the normal flora. Foley catheters are designed as short term devices to drain urine from the bladder. 
However, in recent years, these have been increasingly employed as long-term medical devices, 
remaining in situ for up to 28 days (Donlan et al., 2001). The extended use of catheters means that 
they are more likely to become colonised by microbial species. Mitchell et al. (2016) reported that of 
approximately 170,000 patients admitted to hospitals, 1.73% developed a Hospital Associated 
Urinary Tract Infections (HAUTIs), and that HAUTIs are responsible for 17% of all Health Care 
Associated Infections (HCAIs).    
 
1.2 Catheter-Associated Urinary Tract Infections (CAUTIs) 
Escherichia coli and Proteus mirabilis are key nosocomial pathogens, annually reported to be the 
infective agents most commonly associated with CAUTI. In 2013, Melzer & Welch reported that from 
CAUTI patients, the most routinely isolated organisms were E. coli (43.4%), and Pr. mirabilis, (13.3%). 
Whilst being primarily an intestinal bacterium, E. coli strains capable of causing uropathogenic 
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disease are referred to as UPEC E. coli. In the USA, CAUTI have been estimated to account for 
450,000 cases of nosocomial infections, at a cost of approximately $350m (Nowatzki et al., 2012). 
Whilst the virulence factors required for pathogenesis are not fully understood, it has been 
hypothesised that UPEC strains initiate incidents of disease by first adhering to the surface by 
expression of type 1 fimbriae, or by involvement of the O, H and K serotypes (Mobley et al., 1987).  
Similarly, the physicochemical surface properties have been implicated as a mechanism for P. 
mirabilis cells switching (Allison and Hughes, 1991; Rauprich et al., 1996) between cycles of 
swarming and periods of colonisation and consolidation (Rauprich et al., 1996). In support of this 
research, denser surfaces have also been shown to prevent the swarming phenomenon leading to 
site specific cellular attachment (Shapiro and Trubatch, 1991; Itoh et al., 1999).  
Biofilms are an heterogeneous matrix of exopolymers produced by microbial cells (bacteria or fungi), 
where the microbial cells are adherent upon a substratum, such as an indwelling catheter. The cells 
utilise host-derived compounds such as carbohydrates or proteins to create a protective “shell” 
around their cells. This acts to impede the entry of chemicals such as antibiotics (Lynch & Robertson, 
2008), thus providing a relatively safe environment for the cells to develop. In the biofilm phase, 
individual cells express quorum sensing molecules (Miller and Bassler, 2001). These become 
concentrated within the biofilm matrix, and, once a threshold population is reached, the cumulative 
level of quorum sensing molecules trigger a physiologic change within individual bacterial cells. This 
leads to an up-regulation of biofilm-associated genes, and the activation of multicellular behaviour 
between bacterial cells in, as opposed to individual cell behaviour. Such processes are often 
specifically linked to disease virulence, and can include the up-regulation of motility factors 
(Bragonzi et al., 2009), as well as those associated with resistance to neutrophil-mediated killing 
(Bianconi et al., 2011). It is the quorum-induced effect that results in the bacterium expressing 
toxins, and thus presenting a virulence profile relating to disease states such as urinary tract 
infections resulting from the colonisation of catheters. 
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Biofilm formation on catheters is also associated with increased resistance to antibiotics commonly 
prescribed to treat CAUTI. A recent study in Pakistan stated that 73.4% isolates recovered from 
catherterised patients were biofilm producers (Sabir et al., 2017). This study also revealed that          
E. coli was the most routinely isolated organism, with the highest rate of resistance amongst biofilm-
producing species was determined to be 87.5% to ampicillin. In 2016, Rahimi et al. reported that 105 
from 108 methicillin resistant Staphylococccus aureus strains recovered from patients demonstrated 
a multiply resistant phenotype, and that 82.4% demonstrated resistance to over 10 antibiotics.  
Further research in Australia, in 2015, revealed that 40% of isolates associated with bloodstream 
infections & catheter use were identified as E. coli, which were note dto be Extended Spectrum Beta-
Lactamase producers (Bursle et al., 2015). This study also revealed that catheterisation increased the 
risk of an associated bloodstream infection developing, and importantly, that 56% of catheterisation 
events were unnecessary.  
 
1.3 Catheter Coatings 
The development of novel catheter coatings with anti-fouling (Ding et al.2012), antibacterial 
(Böswald et al., 1999) and hydrophilic properties (Hedlund et al., 2001) have been developed to 
modulate microbial attachment, disease pathogenesis and by decreasing microbial colonisation 
extend the working life of the device. To date, these developments have been limited by the long 
term durability of the coatings (Kaye et al., 1994; Stickler 1996). In such instances, the coating serves 
to delay the bacterial colonisation rather than prevent it, suggesting that future advances in 
preventing CAUTIs should focus the development of non-degradable coatings and a greater 
understanding of material science. 
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Catheters like all indwelling biomaterials must be able to perform their intended function without 
eliciting undesirable side effects on the local cells and tissues. Biocompatibility is dependent on the 
physical and physicochemical properties of the device, whether the material is toxic, and whether 
the device will leach its constituents or particulate material in to the surrounding milieu. An 
understanding of the chemical properties of the device is crucial, as complications due to reduced 
biocompatibility can have serious concerns for patient health. Such complications include: allergic 
response to the material (Warmuth and Beltrani, 1997), encrustation due to bacterial biofilm 
formation (Tenke et al., 2004), and infection resulting from bacterial entry in to underlying tissues 
(Arciola et al., 2004). However, more subtly, recent studies have highlighted the ability of silicone to 
induce a proinflammatory state in human cells (Bhaskar et al, 2015), thus further complicating the 
host response to the infection and subsequent biofilm formation. This research underlines the need 
to investigate the biological effects of materials used to construct biomedical devices from the 
perspective of both the patient, and the infectious organisms. 
1.4 Calixarene 
Calixarene’s are cyclic oligomers produced by the reaction of phenols and aldehydes. They share 
structural similarities with crown ethers, and cydodextrins, and are widely used in the recognition of 
biological molecules (Stone et al., 2002). Biological recognition has largely focussed on interactions 
with amino acids and proteins of the cell surface membrane (Arena et al., 2000; de Fátima et al., 
2009; Gualbert et al., 2009). However recently, antimicrobial properties and good mammalian cell 
biocompatibility has also been reported (Mourer et al., 2010). These compounds have also 
demonstrated antimicrobial activity against fungi (Coimbra de Oliveira et al., 2012), Gram positive 
and Gram negative bacteria (Grare et al., 2007), and the HIV virus (Zeng et al., 2013), suggesting that 
these compounds could present a novel platform for the development of new antimicrobial agents.  
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Whilst insoluble in water, when combined with moieties such as polyethylene, the compound 
becomes water soluble, and can act as a potent drug delivery scaffold and interact with biological 
systems, believed to be initiated through binding to the cell membrane (Saluja and Singh Sekhon, 
2013). Anchoring the calixarene to a silicone substratum used to construct medical devices such as 
catheters could present an alternative solution to prevent or reduce the level of colonisation by 
bacteria and fungi associated with nosocomial infections.  Preserving the antimicrobial activity of the 
calixarene molecule whilst allowing binding to the substratum is therefore pivotal if these avenues 
of research are to be successful. 
1.5 Aims of the Study 
The purpose of this study was to two-fold, firstly to evaluate the efficacy of a novel polyethylene 
glycol-bound calixarene coating against a range of human pathogens over 3, 7 and 10 days to reflect 
clinically relevant time points of human catheterisation. Day 3 represents the idea invivo usage 
period, whilst days 7 and 10 are extensions of this to monitor bacterial colony development. 
Secondly, to evaluate its biocompatibility for use in biological systems. The experiments were 
designed to determine the effect of the full coating and its constituent parts on a range of cells, both 
mammalian and bacterial. The study focused on the long term efficacy of the polymer on different 
silicone substrates in terms of coating stability, toxicity to mammalian cells and its ability to prevent 
initial attachment and long-term colonisation of Pr. mirabilis and E. coli. 
 
2 Materials and Methods 
The silicone discs used throughout these experiments were sourced from three different companies 
in the UK [Clinical grade silicone cured with Acetic Acid (Dow, UK), Medical grade silicone cured with 
cerium/barium (Goodfellows, UK) and Platinum cured medical grade silicone (GB Silicone, UK)], and 
measured 10mm in diameter, and less than 0.5 mm in thickness. The samples were removed from 
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the delivery plate and washed prior to triplicate rinsing in PBS. The material was then submerged in 
70% ethanol and allowed to air dry in sterile conditions prior to UV (wavelength of 250nm) 
sterilisation. 
2.1 Minimum Inhibitory and Cidal Concentration testing of the Calixarene coating 
Minimum inhibitory and bactericidal concentrations (MICs and MBCs, respectively) were determined 
for each of the polymer components against human urinary tract pathogens, prior to its attachment 
to the substratum. The full range of compounds tested is as follows: the full coating; the coating 
surface anchor; the coating-PEG attachment unit; the coating-PEG attachment and surface anchor 
combined together; and finally, the solution (phenolic composition) used to deposit the coating on 
to the catheter surface (0.5% w/v). The microbial human pathogens used in this study were obtained 
from the culture collection of the School of Pharmacy and Biomolecular Sciences, at the University of 
Brighton. They are: Escherichia coli NCTC 10418 and Proteus mirabilis NCTC 11938; and the minimum 
inhibitory and cidal concentrations were determined using the method published by the British 
Society of Antimicrobial Chemotherapy (BSAC; Andrews et al., 2006). 
2.2 Bacterial Growth on substrate silicone spiked with the deposition solution 
The three types of silicone were assessed for their ability to support in vitro growth of Pr. mirabilis, 
being one of the principle uropathogenic organisms. A total of 18 discs were used, 6 of each silicone, 
three of each coated with the calixarene polymer. Growth was determined at time points 24 and 48 
hours incubation at 37°C. At time zero, the test wells were spiked with the deposition solution, and 
the resulting effect on microbial growth determined by serial dilution and spread plating. 
Silicone discs were aseptically transferred into six well plates, and 2.6 mL of TSB was added to each 
well to submerge the disc, and 300 µL of deposition solution was added to each well to adjust the 
concentration to 0.02%, as this was stated to be the concentration used to coat silicone samples by 
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the manufacturer.  Finally, 100 µL of an overnight culture (approximately 1x107 CFU) was used to 
inoculate the samples, the plates were sealed and incubated.  
2.3 Growth of biofilms on Calixarene coated and uncoated silicone substrates 
Calixarene coated and non-coated silicone discs were aseptically transferred to 6-well plates and 
sterilized as described above. Each disc was subsequently immersed into 5 mL of 1/10th strength 
TSB and seeded with an overnight culture of either Pr. mirabilis or E. coli, respectively , and left for 
one hour at room temperature. The discs were washed in PBS, incubated and enumerated as 
previously described, except using artificial urine as the growth medium (see below for the 
formulation of the artificial urine medium). Biofilms for E. coli and Pr. mirabilis were enumerated at 
days three, seven and ten, and replicate discs were fixed for SEM at each time point, using the 
methodology outlined below. 
Artificial urine (AU) was adapted from the methodology published by Stickler et al. (1999). The final 
constitution of the stock media was as follows, for 100mL total volume: 0.236g sodium disulphate, 
0.065g magnesium chloride, 0.46g trisodium citrate,  0.002g sodium oxalate, 0.28g potassium 
dihydrogen orthophosphate, 0.16g potassium chloride, 0.1g ammonium chloride, 0.5g gelatin, and 
0.1g tryptone soy broth. All media was purchased from Fisher Scientific (UK), and reverse osmosis 
water was used to constitute the medium, which was subsequently autoclaved at 121°C for 15 
minutes. A stock solution of urea and calcium chloride was also constituted; comprising 25g of urea 
and 0.65g of calcium chloride in 400 mL of reverse osmosis water was also added. This was filter 
sterilized using a 0.2µm syringe filter (Sartorius) in a Class 2 Microbiology hood. Next, 92 mL of the 
stock medium was added to 8 mL of the urea/calcium chloride solution to make the working solution 
of artificial urine medium.  
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2.4 Scanning Electron Microscopy 
Samples were fixed using 2.5% glutaraldehyde (manually prepared) in cacodylate buffer (pH 7.4) for 
one hour to remove the ‘natural’ water. The samples were rinsed in cacodylate buffer, and then 
dehydrated in serially increasing concentrations of ethanol (25%, 50%, 75% and two washes in 97%). 
Each wash lasted for thirty minutes, and was conducted at room temperature and atmospheric 
pressure. Samples were examined using a Zeiss EVO SEM (Oxford Instruments, UK). 
2.5 Direct contact tests with fibroblast cell line 
Sterilized calixarene coated samples (n=6), non-coated silicone samples (n=6) and tissue culture 
plastic (TCP) controls (n=6) were pre-conditioned with DMEM+10% FCS prior to seeding with mouse 
3T3 fibroblasts at 1x104 cells per cm2. The cells were incubated for 72h, with time points at 24, 48 
and 72h. At each time point, the samples were stained with hoechst propidium iodide (HPI) to 
identify live, dead and apoptotic/necrotic cells. Cells stained blue are alive and viable, red cells 
indicate DNA damage akin to cell death and apoptotic cells appear as bright blue spheres indicative 
of membrane clumping. Six random fields of view were imaged using fluorescent microscopy (MAKE 
MODEL) and total cell number enumerated to assess cellular adhesion, whilst live cell counts were 
used to study cell viability and proliferation. 
2.6  Direct contact of unbound polymer with fibroblast cell line 
The polymer loading solution was diluted down by factors of 10 to a 0 concentration. 3T3 fibroblasts 
were seeded 1x104 per cm2 onto TCP (n=6) and allowed to adhere for 30 minutes in 1ml 
DMEM+10%FCS, the adhesion medium was removed and replaced with DMEM+10%FCS containing 
the unbound polymer (0.2, 0.02, 0.002, 0.0002, 0.00002% and 0) the cells were incubated for 72 
hours at 37°C. 
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2.7 Indirect contact testing with fibroblast cell line 
3T3 fibroblasts were seeded 1x104 per cm2 onto pre-conditioned TCP plates (n=6). The cells were 
allowed to adhere in pre conditioning medium (DEME+10% FCS) prior to its replacement with 900ul 
fresh DMEM+10% FCA spiked with 100ul extract medium. The plate was then placed in the incubator 
(37°C ) for 72 hours with time points at 24 and 48hrs. At each time point the cells were removed and 
stained using HPI (as described in section 2.5). 
2.7.1 Extract medium  
Extracts were derived to stimulate and/or exaggerate the clinical conditions to determine any 
potential hazard, they are not designed to alter or damage the test surface or chemical structure of 
the surface. In this study culture medium with serum (DMEM+10%FCS) was the extraction vehicle; 
this was chosen to allow the extraction of both polar and non-polar substances. The extraction was 
performed in sterile conditions using aseptic technique in accordance with ISO 10993-12, for a 
period of 24h at 37°C.  Briefly, the sterilized coated (n=6) and non-coated (n=6) discs were placed in 
a sterile TCP 24 well plate, each samples was covered in 1ml DMEM+10%FCS and placed in the 
incubator for 24h at 37°C, standard culture media (DMEM+10% FCS) was used as a control. Once 
completed the supernatant was removed into separate, labelled Eppendorfs and placed in the fridge 
ready for use in the indirect assay. The substrate material was then discarded. 
2.8 Material mapping  
The clinical grade silicone samples were prepared by washing and sterilizing, prior to being coated in 
platinum. The platinum and cerium/barium cured medical grade samples were studied in their as 
received state by being mounted directly onto the SEM stubs and coated in platinum. They were 
investigated by backscatter imaging using the Aztec EDS system, Zeiss EVO SEM (Oxford Instruments, 
UK), the samples were studied using point and elemental mapping modes. 
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2.9 Statistical Analysis 
Microbiological results were interpreted using Analysis of Variance Statistics, using Minitab® 16 
(USA). Two-Way tests were employed, using a 0.05 cut-off point. Data for calixerene-coated samples 
were compared to analogous growth samples using un-coated silicone samples, at each specific time 
point stated. Biofilm percentage changes between time points were determined by using the 
previous time point as a reference, and nominally determining that to be 100% of the biofilm size to 
which subsequent growth was measured against. 
3 Results  
3.1 MIC and MBC analysis 
The MIC and MBC values for each of the components of the coating, and the full coating are 
shown in Tables 1 & 2. These values represent results for planktonic cultures, in vitro.  
 
The MIC and MBC values for the deposition solution against each of the test organisms in 
planktonic culture was determined to be 0.2% w/v, in vitro. 
 
3.2 Biofilm response to Calixerene challenge 
The Pr. mirabilis and E. coli biofilms increased in size on both the coated & uncoated samples (Figure 
1). However, whilst the E. coli biofilms increased in a fairly straight increase on both coated & 
uncoated samples, (figure 1b), the Pr. mirabilis biofilms increased significantly between days 3 and 7, 
only to decrease by day ten on coated samples, whilst an increase between all time points was 
observed for uncoated samples (Figure 1a).  Statistical analysis (T-test and ANOVA; Excel® and 
Minitab®), the results indicate no statistically significant difference for either species over the three 
time periods (E. coli on coated & uncoated substrate: p = 0.14; Pr. mirabilis on coated & uncoated 
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substrate: p = 0.28; E. coli c.f. Pr. mirabilis on coated substrate: p = 0.17). However, analysis reveals a 
significant difference between the growth profiles of the two closely related test bacteria on the 
uncoated substrate during the same test conditions (E. coli c.f. Pr. mirabilis on uncoated substrate: p 
= 0.02). This indicates that different species respond differently to substrates, and that catheter 
models for microbial colonisation should be treated cautiously when extrapolating to suggest the 
response of a chemical coating in relation to other infectious microorganisms.  
 
Scanning electron microscopy (SEM) revealed that E. coli biofilms (Figure 2) developed much more 
slowly than those for Pr. mirabilis (Figure 3). The formation of crystals were also identified on 
uncoated silicone surface colonised by the Pr. mirabilis (micrographs not shown). 
 
3.3 Fibroblast analysis toxicity 
The direct contact assay showed reduced viability of fibroblast cells seeded on the coated clinical 
grade silicone (Dow, UK) and uncoated clinical grade silicone (Dow, UK) where the cells were 
observed to stain positive for apoptosis (red) and appeared to be clustered together (data not 
shown). At 24 hours, cells seeded on the medical grade (silicone (S130343, 650-236-68, Goodfellows, 
UK) were viable and well dispersed across the surface of the sample. Similarly, cells seeded on to the 
platinum cured medical grade silicone showed no positive apoptosis staining in either the coated or 
non-coated materials. Similar findings were noted in the direct contact assay at 48 hours. 
Interestingly, the uncoated platinum cured sample at 48hour incubation looked to encourage 
cellular aggregation unlike the more randomly distributed cells observed on the control and coated 
substrates (Figure 4). The incubation of the cells with various dilutions of the unbound polymer was 
investigated to further understand if the direct contact toxicity was a result of the polymer coating 
or the underlying substrate material.  The images in Figure 5 highlight viable (blue) cells grown in the 
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presence of up to a concentration of 0.002% dilution of the initial 2% v/v loading solution. The cells 
are comparable in size, number and distribution to those on the control sample.  
Indirect contact testing at 24 hours showed all of the fibroblast cells in each of the extract media 
were viable with no sign of apoptosis. The same findings were apparent at the 48 hour time point, 
indicating no release of toxic leachates from the test samples. In contrast, the 72 hour HPI stain 
highlighted a delayed toxic (red stain) response in cells exposed to the extract medium from the 
clinical grade calixarene coated and non-coated samples (Figure 6).  Conversely the extract from the 
platinum cured medical grade silicone (GB Silicone, UK) showed no evidence of apoptotic staining 
was observed on either the uncoated or coated samples at any of the time points studied including 
those incubated for 72 hours (Figure 7). This was confirmed by cell counts performed at 24 and 48 
hours, respectively (Figure 8). 
3.4 Material Analysis 
The bulk properties of silicone were identified as silicone, oxygen and carbon, point analysis 
identified particulate contaminants up to 25um in diameter as nickel, chromium, iron and tin. The 
particulate material is more evident on the clinical grade material regardless of calixarene coating. 
4.0 Discussion 
This study highlights the pivotal impact of the substrate material on mammalian and bacterial cell 
survival. The MIC and MBC highlight that E. coli and Pr. mirabilis present different tolerance profiles 
for each of the individual test compounds. The addition of the anchor didn’t alter the response of 
either pathogen; in fact the result was the same as that in contact with the free calixarene. This 
implies any subsequent change in inhibitory effect can be attributed to the substrate material. The 
dramatic increase in Pr. mirabilis biofilm formation over the experimental duration on the non-
coated silicone when compared to the lack of increase in biofilm size in the calixarene coated 
silicone supports this data. Indeed, studies by Shapiro and Trubatch, 1991; Itoh et al., 1999 also 
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demonstrated that biofilm nature can be greatly affected by their ability to adhere onto the 
biomaterial surface.  
However, caution must be applied when comparing the growth response of one organism to 
another. The data presented in this paper clearly indicates that, despite E. coli and Pr. mirabilis being 
closely related bacterial species, the two will develop differently on silicone catheter substrates. 
Models of infectious diseases must be evaluated in relation to the known or most likely infectious 
organisms associated with the diseases being investigated. This model would need adjusting for 
studies on Candidiasis, for example.  
Scanning electron micrographs revealed the development of distinct multi-layered biofilms for both 
E. coli and Pr. mirabilis on the uncoated medical grade, platinum-cured silicone. Similarly to the MIC 
and MBC findings, marked differences were noted between the two species, the E. coli biofilms 
developed much more slowly when compared to Pr .mirabilis, it is theorised that this is as a result of 
the swimming and swarming phenotypes exhibited by Pr. mirabilis, and the positive effects that this 
has on bacterial growth for this species. The Pr. mirabilis cultured on the non-coated silicone 
substrates showed an increased formation of numerous crystal on the substrate surface, the crystals 
were as assumed to be struvite crystals. The formation of ammonia in vivo by bacterial species 
including Pr. mirabilis is well documented. The bacteria produce a mettaloeznyme capable of 
hydrolysing urea in to ammonia, resulting in an increased pH of the local host environment (Mobley 
et al., 1995). The ammonia has binds to divalent cations naturally occurring in the urine, to begin 
crystal formation.  It has been suggested that increased ammonia production can cause damage to 
the uroepithelial layer of the host, leading to the release of cellular nutrients, which might cause 
increased bacterial growth (Johnson et al., 1993). In this situation, the formation of crystals and toxic 
damage to the human cell layers would no doubt cause great discomfort to a catheterised patient. 
The reduction in E. coli and Pr. mirabilis biofilm formation, and crystal formation for urease negative 
species such as Pr. mirabilis, that is afforded by calixerene coatings might prove advantageous to the 
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development of future coating models. However, the exact nature of the interactions between such 
compounds as ammonia & struvite with calixerene needs to be fully determined, for both bound and 
unbound calixerene. 
 
The clinical grade silicone showed an increased cell apoptosis when incubated with the mammalian 
fibroblast cell line this was attributed to the underlying substrate toxicity as a result of the use of 
acetic acid in the curing process. As found by Okabe et al, the use of acetic acid in mammalian cell 
culture induces cell death and apoptosis. As a result any effect of the polymer calixarene polymer 
coating on this substrate was masked. The evidence of substrate based toxicity was further 
confirmed by the lack of apoptosis identified in either of the medical grade silicones, both of which 
promoted viable adhesion with normal cell morphology. Indeed the platinum cured substrate was 
shown to promote cell adhesion with evidence of cellular aggregation, the addition of the calixarene 
coating reduced the nature of the adhesion with fewer individual cells noted, supporting the 
antifouling nature of the polymer as described by Saluja and Singh Sekhon, 2013.  
Systemic toxicity was investigated to ensure no leachate or peeling of the material could induce a 
further host response. The medical grade samples showed no toxic leachate over the tested time 
period however this was not the case for the clinical sample which showed an increase in cell 
apoptosis at 72 hours, this was identified as a response to the release of acetic acid curing agent into 
the media which underwent a colour change due to its phenol content from red/pink to orange/ 
yellow. 
The clinical grade  silicone (Dow, UK) uncoated and coated with the calixarene polymer had bulk 
properties of silicone, oxygen and carbon, in each case particulate contaminants were ,  investigated 
using point analysis and identified as nickel, chromium, iron and tin possibly artefacts of the 
manufacturing process.  Nanoparticulate material is evident the clinical grade silicone regardless of 
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the presence or absence of the calixarene coating, suggesting the contaminants are embedded in 
the material bulk itself. 
These imperfections are likely to be as a result of the manufacturing process, and it is unlikely that 
they would cause the toxicity identified during the direct contact experiments. Similar contaminants 
were observed when mapping the medical grade silicone (Goodfellows, UK), which also recorded the 
presence of surface debris, comprised of metallic elements such as zirconium and titanium. The 
platinum cured medical grade silicone (GB Silicone, UK) showed fewer areas of nano-particulate 
contamination and where found they were in the main part natural salts and metal such as calcium 
and bismuth. Individual particles containing copper, zirconium and titanium were found but not as 
widespread as with the earlier materials, again all are commonly found in industrial manufacturing 
settings. 
The use of material mapping and image analyses provided crucial data which identify potential 
reasons why material chemistry needs to be precise in order to have a positive effect on biomedical 
device function, and consequently on patient suffering. It is essential to fully investigate the toxicity 
of potential biomaterials by simple, inexpensive testing prior to their inclusion in test matrices. In 
this study, the antimicrobial effect of the calixarene coating was negated by the presence of toxic 
particulate matter on the surface of the biomaterials. This study has produced valuable conclusions, 
which can be summarised as follows. 
Whilst combining individual monomer units of the calixarene polymer did not decrease the 
effectiveness of the combined calixarene polymer, in terms of minimum inhibitory concentration 
(MIC) or minimum bactericidal concentration (MBC), nor did the addition of the anchor molecules 
which facilitate adhesion to the silicone, in vitro. The unbound polymer appears to have species 
modality, whereby the MIC and MBC are similar for Pr. mirabilis, but the MIC is lower than the MBC 
for E. coli, which is more sensitive to lower concentrations of the unbound calixarene molecule. 
Mammalian cells exhibited a toxic response only at the two highest concentrations of the loading 
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solution, below which no adverse observations were noted up to 72 hours, but the polymer is non-
toxic to mammalian cells when grafted on to a non-toxic substrate (i.e. platinum cured silicon) over 
24, 48 and 72 hours in both direct and indirect testing.  
The initial silicone substrates tested were toxic due to the presence of compounds remaining from 
the curing/manufacturing process, resulting in a level of cellular adaptation occurring in the first 72 
hours of incubation with the non-platinum cured coated and uncoated silicone extract medium. The 
similarity in the two samples supports the theory that it is the substrate material which is leaching 
the toxic compound, as any toxicity from the coating would not be observed in the uncoated sample. 
Although positive, it is essential to keep in mind that the substrate toxicity may be masking any 
coating toxicity. These results support the data observed in the direct contact study and prompt the 
conclusion that the substrate material in the earlier investigations was probably the main causal 
agent for the observed toxicity. Indeed, this data taken in conjunction with the data recorded in the 
unbound polymer study further supports the non-toxic nature of the calixarene polymer. Cerium 
was also identified leading us to theorize that is was this easily oxidisable metal which was used in 
the curing of this silicone. Barium was also identified an alkaline metal often used to scavenge air in 
a vacuum system; again it is proposed that this is another curing artefact.   
This paper attempts to highlight some of the issues relating to material chemistry, and the intended 
application of a substrate for use as a biomedical device. The results from this study show that the 
grade of silicone affects its toxicity to both eukaryotic & prokaryotic cells, and that this should be 
used as a marker to influence the selection of materials in device design. Further, the potential for 
adverse effects on the host tissues must be demonstrated to be negligible before a product can be 
promoted for use. The potential for calixerene coating to reduce bacterial biofilm formation has 
been demonstrated. But, this must be acknowledged to be dependent on material selection prior to 
use.  
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In April 2015, the UK NHS (National Health Service) estimated that the £1bn was spent on treating 
HCAIs; with £56m of this money associated with post-discharge care (Mantle, 2015). It is understood 
that 172% of all HCAIs in the UK are linked to UTIs (Loveday et al., 2014). In the USA, in 2013, it was 
estimated that approximately $45bn was spent on direct hospital costs for CAUTIs, with 
approximately 100,000 deaths annually linked to this type of infection (Kennedy et al., 2013). These 
statistics underline the pivotal importance of assigning a correct therapeutic regime for each patient, 
and the need to understand the interaction between microbial cell and substrate at the cellular 
level. Further research is needed to understand how novel materials interact with human cells to 
ameliorate suffering and reduce morbidity times, but also to reduce overall healthcare costs to the 
provider.  
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Figures list 
Figure 1. The percentage change in biofilm density over a ten day period with Calixarene coated and 
non-coated substrates, a) Pr. Mirabilis, b) E. coli. 
Figure 2. Scanning electron micrographs revealing the development of E. coli biofilms on coated and 
uncoated silicone sample after incubation in artificial urine at 37 oC. (a) coated silicone at day 3; (b) 
uncoated silicone at day 3; (c) coated silicone at day 10; (d) uncoated silicone at day 10. 
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Figure 3. Scanning electron micrographs revealing the development of Pr. mirabilis biofilms on 
coated and uncoated silicone sample after incubation in artificial urine at 37 oC. (a) coated silicone 
at day 3; (b) uncoated silicone at day 3 with crystal formation highlighted; (c) coated silicone at day 
10; (d) uncoated silicone at day 10. 
Figure 4. HPI staining of mouse 3T3 fibroblasts cells seeded onto the Calixarene coated and non-
coated platinum cured medical grade substrate and a tissue culture plastic control at 24 and 48 
hours (x20 magnification)(size bar 50um). 
Figure 5. HPI staining of a range of percentage dilutions (0.2%, 0.02%, 0.002%, 0.0002% and 
0.00002%) of the initial 2% v/v loading solution of the unbound polymer in contact with mouse 
fibroblasts for 72 hours (x20 magnification)(size bar 50um). 
Figure 6.  HPI staining of fibroblast cells incubated with the extract of the calixarene coated clinical 
grade and non-coated clinical grade substrate and a tissue culture plastic control at 24, 48 and 72 
hours (x20 magnification)(size bar 50um). 
Figure 7. HPI staining of fibroblast cells incubated with the extract of the calixarene coated platinum 
cured medical grade substrate, non-coated platinum cured medical grade substrate,  and a tissue 
culture plastic control at 72 hours (x20 magnification)(size bar 50um). 
Figure 8. Mouse fibroblast cell number at 24 and 48 hours on the calixarene coated platinum cured 
medical grade substrate, non-coated platinum cured medical grade substrate and a tissue culture 
plastic control at 24 and 48 hours. 
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Table 1. MIC values for each of the test compounds against each of the test organisms, in vitro. 
Test Compound MIC (w/v)
Escherichia coli Proteus mirabilis
Coating-PEG attachment 
and surface anchor  
0.0625 0.0625
Coating-PEG attachment 0.03125 0.03125
Surface anchor 0.03125 0.25
Full coating 0.03125 0.25
  
 
Table 2. MBC values for each of the test compounds against each of the test organisms, in vitro. 
Test Compound MBC (w/v)
Escherichia coli Proteus mirabilis
Coating-PEG attachment 
and surface anchor 
0.125 0.125
Coating-PEG attachment 0.0625 0.125
Surface anchor 0.0625 0.25
Full coating 0.0625 0.25
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